Aphria Inc.’s U.S.-listed shares slid 9% Tuesday before paring their losses, after the Canadian cannabis company posted weaker-than-expected revenue for its fiscal second quarter and revised down its guidance to reflect issues including a slower rollout of retail locations in Ontario. READ MORE: https://finance.yahoo.com/m/f7e39e8a-8d8f-39b7-8b05-1aeda9418b01/aphria-stock-slides-on.html?.tsrc=rss
Aphria Inc.’s U.S.-listed shares slid 9% Tuesday before paring their losses, after the Canadian cannabis company posted weaker-than-expected revenue for its fiscal second quarter and revised down its guidance to reflect issues including a slower rollout of retail locations in Ontario. READ MORE: https://finance.yahoo.com/m/f7e39e8a-8d8f-39b7-8b05-1aeda9418b01/aphria-stock-slides-on.html?.tsrc=rss
Aphria Inc.’s U.S.-listed shares slid 9% Tuesday, after the Canadian cannabis company posted weaker-than-expected revenue for its fiscal second quarter and revised down its guidance to reflect issues including a slower rollout of retail locations in Ontario. READ MORE: https://finance.yahoo.com/m/f7e39e8a-8d8f-39b7-8b05-1aeda9418b01/aphria-stock-slides-9%25-to.html?.tsrc=rss
The Canadian pot producer blames a change in Germany’s reimbursement for medical marijuana, but says demand is strong. Shares are down 8%. READ MORE: https://finance.yahoo.com/m/7e82556f-c5c7-3765-b02c-a9db24dd44eb/aphria-stock-gets-hammered.html?.tsrc=rss
Aphria Inc. Announces Third Consecutive Quarter of Positive Adjusted EBITDA and a 46% Increase in Adult-Use Cannabis Revenue From Prior Quarter Adjusted EBITDA from Cannabis Operations of $3.4 Million Increased 155% from Prior Quarter Strengthened Balance Sheet and Cash Position Received EU GMP compliance confirmation for ARA-Avanti Rx Analytics Updates Fiscal Year 2020 Outlook LEAMINGTON, […] READ MORE: https://www.newcannabisventures.com/aphria-reduces-outlook-as-q2-cannabis-sales-increase-9-5-sequentially-to-33-7-million/
The new year is off to a rocky start for Aphria Inc. The Ontario-based medical marijuana and cannabis oil company has issued a voluntary recall of its new line of vape pens because some of its cartridges have a leaking issue. “Out of an abundance of caution we asked provincial customers to return certain initially shipped ‘510 cartridges’ that did…
Aphria’s stock price has risen 8.9% since reporting its Q1 earnings on October 15. The cannabis sector’s weakness offset some of these gains. READ MORE: https://finance.yahoo.com/m/e1aa4e39-f713-37cf-88e7-3b1ccca74cc8/does-aphria%E2%80%99s-valuation-look.html?.tsrc=rss
On November 4, Aphria (APHA) announced the receipt of a cultivation license from Health Canada for its Aphria Diamond cannabis greenhouse facility. READ MORE: https://finance.yahoo.com/m/9c4df38a-b611-3c67-9ecc-f47205604633/all-you-need-to-know-about.html?.tsrc=rss
Supreme Cannabis Strengthens Sales Strategy with New Senior Vice President of Commercial Joel Toguri joins as Senior Vice President of Commercial Supreme Cannabis strengthens senior team with the addition of experienced sales executive Mr. Toguri brings over 20 years of regulated industry expertise to Supreme Cannabis TORONTO, Nov. 4, 2019 /CNW/ – The Supreme Cannabis […] READ MORE: https://www.newcannabisventures.com/supreme-cannabis-names-former-aphria-sales-exec-to-lead-sales/
Aphria (APHA) reported its results for the first quarter of fiscal 2020 on October 15. Since then, the stock has fallen 7%. READ MORE: https://finance.yahoo.com/m/d34b64d0-f80d-3f64-888b-7d11887deaa3/aphria:-why-jefferies.html?.tsrc=rss
SAN RAMON, Calif.–(BUSINESS WIRE)– #CloudERP–Aphria Inc. implements Rootstock Cloud ERP and ComplianceQuest’s EQMS to support its growth trajectory in the global cannabis market. READ MORE: http://www.businesswire.com/news/home/20191028005064/en/Aphria-Leading-Global-Cannabis-Company-Implements-Rootstock/?feedref=JjAwJuNHiystnCoBq_hl-W8j9Oi60kFTomUxRDB8jhB7TDOU5CqE9t5WwBA1inzlrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3kCXJZE-1b1nXn968wYfofVIbE9ZC1pD3bt6lQgRU5j6g==
On October 15, Aphria reported its Q1 earnings. Although Aphria’s revenue came in lower than expected, its EBITDA and EPS beat analysts’ expectations. READ MORE: https://finance.yahoo.com/m/b3314a65-1012-3a08-8911-01233aacbee6/aphria:-analysts%E2%80%99-ratings-and.html?.tsrc=rss